Photo: IMTEK / Bernd Müller
The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz and a neurosurgical research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.
In 2014 Stieglitz and his colleague Dr. Dennis Plachta developed a novel cuff with electrodes for nerve stimulation. The startup company neuroloop aims to develop the novel technology into a market-ready product in the coming years with a team of 15 engineers and scientists. The company expects to receive a license for the market-ready product in 2021.
“For start-ups, funding by a strong strategic partner like Aesculap is a very interesting alternative to classic venture capital funding from the financial market,” explains Managing Director Dr. Michael Lauk. “The foundation of the company is the first step. The more ambitious part of the task no doubt still lies ahead of us. The team is looking forward to the challenges involved in developing the technology and getting it licensed in the coming years.”